Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Số trang: 7
Loại file: pdf
Dung lượng: 1.62 MB
Lượt xem: 12
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Sorafenib is a multi-kinase inhibitor that shows antitumor activity in advanced hepatocellular carcinoma. Sorafenib exerts a regulatory effect on immune cells, including T cells, natural killer cells and dendritic cells.
Nội dung trích xuất từ tài liệu:
Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Nội dung trích xuất từ tài liệu:
Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Plasmacytoid dendritic cells Hepatocellular carcinoma Multi-kinase inhibitor Antitumor activityGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 118 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0